VF
LEGN icon

Virtu Financial’s Legend Biotech LEGN Stock Holding History

Virtu Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
+8,831
New +$238K 0.01% 808
2026
Q1 		– Sell
-13,690
Closed -$298K – 2006
2025
Q4 		$298K Buy
+13,690
New +$392K 0.01% 855
2021
Q3 		– Sell
-7,375
Closed -$303K – 1748
2021
Q2 		$303K Buy
+7,375
New +$251K 0.03% 716

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Virtu Financial's LEGN Position: Q2 2026 in Review

Virtu Financial opened a new position in Legend Biotech (LEGN) in Q2 2026: 8,831 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #808 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LEGN as recently as Q4 2025.

Virtu Financial first reported a position in LEGN in Q2 2021 and has held it in 3 quarters since. The position peaked at $303K in Q2 2021. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Virtu Financial held 8,831 shares of Legend Biotech worth $255K as of Q2 2026.
  • Legend Biotech was a new Virtu Financial position in Q2 2026.
  • Legend Biotech made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #808 holding.
  • Virtu Financial first reported a position in Legend Biotech in Q2 2021 and has held it in 3 quarters since.
  • Virtu Financial's Legend Biotech position peaked at $303K in Q2 2021.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.